LaRocca 2006.

Study name	Randomized Pilot Study of Supplemental Iscar in Combination With Gemcitabine vs. Gemcitabine Alone as Second Line Treatment for Advanced Non‐Small Cell Lung Cancer
Methods	Randomized, Open Label, Active Control, Parallel Assignment
Participants	Adults with non‐small cell lung cancer
Interventions	Iscar in combination with Gemcitabine vs. Gemcitabine alone
Outcomes	Immune function and quality of life
Starting date	May 2004
Contact information	http://clinicaltrials.gov/ct2/show/NCT00283478?term=mistletoe&rank=8
Notes	study completed